title: Regulation of pp60c-src synthesis by inducible RNA complementary to c-src mRNA in polyomavirus-transformed rat cells.
abstract: To determine the potential role of pp60c-src in polyomavirus-transformed cells, we constructed a recombinant plasmid with the mouse metallothionein-I promoter upstream of a src gene in an anti-sense orientation. We cotransfected this plasmid into middle tumor antigen-transformed FR3T3 cells with a plasmid containing the neomycin resistance gene, and G418 resistant colonies were selected. Analysis of these cells for pp60c-src expression revealed that 50 of the 200 cellular clones screened were found to have decreased levels of c-src expression when compared with the parental middle tumor antigen-transformed cells. Three independent clones which transcribed the expected 3.6-kilobase src complementary RNA and had levels of pp60c-src kinase activity comparable to that of normal FR3T3 cells were further analyzed. In the presence of Cd2+, these clones grew significantly slower in monolayer cultures than either the parental transformed cells (FR18-1) or FR18-1 cells transfected with the neomycin resistance gene alone. The morphology of these clones in the presence of Cd2+ was distinct from that of either the parental FR18-1 cells or normal FR3T3 cells. The clones expressing the complementary src RNA were found to form fewer colonies in soft agar, form fewer foci on monolayers of normal rat cells, and form tumors more slowly following injection into syngenic rats when compared with parental FR18-1 cells. The results of these studies suggest that the level of pp60c-src kinase activity affects the growth characteristics and transformation properties of polyoma virus-transformed rat cells.
mesh_terms: D000818:Animals; D002104:Cadmium / Q000494:pharmacology; D002472:Cell Transformation, Viral; D004351:Drug Resistance; D008668:Metallothionein / Q000235:genetics; D051379:Mice; D009355:Neomycin / Q000494:pharmacology; D015688:Oncogene Protein pp60(v-src); D011120:Polyomavirus; D011401:Promoter Regions, Genetic; D011494:Protein Kinases / Q000378:metabolism; D012313:RNA / Q000494:pharmacology*; D012333:RNA, Messenger / Q000494:pharmacology*; D051381:Rats; D011994:Recombinant Proteins / Q000378:metabolism; D012191:Retroviridae Proteins / Q000096:biosynthesis*
chemical_list: D012333:RNA, Messenger; D011994:Recombinant Proteins; D012191:Retroviridae Proteins; D002104:Cadmium; D012313:RNA; D008668:Metallothionein; D011494:Protein Kinases; D015688:Oncogene Protein pp60(v-src); D009355:Neomycin